Prot# NN2211-1573: Liraglutide Effect & Action in Diabetes (LEAD3): Effect on Glycemic Control of Liraglutide vs Glimepiride in Type 2 Diabetes [A 52 Wk (w/ 52 Wk Opn-Lbl Extnsn), Dbl-Bld, Mltctr, Rndmzd, Prlll Stdy to Invstgt Sfty & Effccy] Trl Phs: 3a

Project: Research project

Project Details

Effective start/end date8/9/068/10/09


  • Novo Nordisk Inc. (NN2211-1573)